Penumbra, Inc. PEN reported first-quarter 2025 adjusted earnings per share (EPS) of 83 cents, which surpassed the Zacks ...

Researchers compared outcomes associated with conventional excision vs Mohs micrographic surgery among patients with hand and foot melanoma.

Analysts have set 12-month price targets for Penumbra, revealing an average target of $313.83, a high estimate of $340.00, ...

Q1 2025 Earnings Call Transcript April 23, 2025 Boston Scientific Corporation beats earnings expectations. Reported EPS is $0 ...

Q1 2025 thrombectomy revenue reached $226.5 million, an increase of 20.7% year-over-year, with U.S. thrombectomy contributing significantly to this growth. International thrombectomy increased 3.3%, ...

Q1 2025 Earnings Conference Call April 23, 2025 4:30 PM ETCompany ParticipantsCecilia Furlong - Business Development & ...

Detailed price information for Johnson & Johnson (JNJ-N) from The Globe and Mail including charting and trades.

Analysts expect Penumbra to report an earnings per share (EPS) of $0.67. The announcement from Penumbra is eagerly ...

Rising raw material costs are forcing price hikes, potentially boosting revenue, but impacting profit margins. FMCG companies are currently navigating a tough business environment. They are ...

EBIT margin stood at 24.2% as against CNBC-TV18's poll of 24.8%. TCS won deals worth $12.2 billion during the quarter, which was higher than the $10.2 billion in the December quarter.

This could lead to a demand recovery in the second half of FY26. Still, profit margins are under pressure. The high cost of raw materials is making it harder for companies to maintain healthy gross ...